New England Biotech Headlines
Today is July 04, 2009. All times in Eastern Daylight Time.
07/02/2009 - 04:01 PM
Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009
07/01/2009 - 05:00 PM
Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA® Pediatrics
07/01/2009 - 08:00 AM
Bruker Announces Order for World’s First Commercial 263 GHz EPR Spectrometer from the Helmholtz-Zentrum in Berlin for Solar Energy and Photovoltaic Research Applications
07/01/2009 - 08:00 AM
Charles River Announces RMS Succession Plan and Organizational Enhancements
07/01/2009 - 07:30 AM
CombinatoRx and Neuromed Sign Merger Agreement
07/01/2009 - 06:00 AM
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
06/30/2009 - 04:44 PM
FDA Approves Feraheme™ to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
06/30/2009 - 02:30 PM
Aushon Technology Chosen for Small Molecule Microarray Research
06/30/2009 - 01:38 PM
Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
06/30/2009 - 11:35 AM
NMT Medical Secures $4.0 Million Credit Agreement
06/30/2009 - 09:00 AM
New Expanded Atlantis™ Patient-Specific Abutment Compatibility and Material Option for Straumann Implants
06/30/2009 - 08:30 AM
Covidien Recognized as Top Medical Devices Innovator
06/30/2009 - 08:00 AM
Collegium Pharmaceutical Announces the Sale of AllerNaze™ to Lupin
06/30/2009 - 07:30 AM
Dyax Announces Underwriter’s Exercise of Over-allotment Option
06/29/2009 - 06:50 PM
FDA Decision on Feraheme NDA Expected Within Next Few Days
1
2
Next »
About Us
|
Contact Us
|
Privacy Statement
|
Terms of Use
|
© Business Wire 2009